Skip to main content
Caplight Logo









Chromai

Chromai

Private
BeijingFrontier & Industrial Techhttps://www.chromai.com/

Last Round

Strategic

Feb 24, 2026

Total Funding Raised

$22.98M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Chromai is a diagnostic equipment company that develops medical molecular diagnostics and testing technology.

Sector

Frontier & Industrial Tech

Verticals

Biotech Equipment, Computing Hardware, Environmental Monitoring, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

ultra-high-performance liquid chromatographyUHPLCchromatography data systemCDSanalytical instrumentationlab equipmentbiocompatible chromatographypreparative liquid chromatographyautomated sample pre-treatmentSPEFDA 21 CFR Part 11lab automationdomestic substitutionscientific instruments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chromai Comparables

Compare Chromai with similar companies based on industry and business-model similarity.

Chromai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dalian Elite Analytical Instruments Co., Ltd.
83%
Agilent Technologies
69%
PerkinElmer
65%

Chromai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicFeb 24, 2026
Series A ExtensionAug 25, 2025
Series AJun 5, 2023
SeedDec 23, 2021
Pre SeedAug 23, 2021
Angel
Mar 17, 2020

Key People

Founding team and executive leadership

Alex Zhang

CEO Co-Founder

Founding Team

Chromai Investors

Notable investors and investment history

Chromai investors
InvestorRounds
YuanBio Venture CapitalSeries A
Oriza VenturesSeries A
Linear CapitalAngel
Huagai CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 13, 130% of current headcount.

  • Jul 6, 2026

    Open roles increased to 9, 82% of current headcount.

Chromai Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chromai Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chromai's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range10
Year Founded2019
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?